EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The Effects of a Food Supplement, Based on Co-Micronized Palmitoylethanolamide (PEA)–Rutin and Hydroxytyrosol, in Metabolic Syndrome Patients: Preliminary Results

Kevin Cornali iD, Manuela Di Lauro iD, Giulia Marrone iD, Claudia Masci, Giulia Montalto iD, Alfredo Giovannelli, Carlo Schievano iD, Manfredi Tesauro, Massimo Pieri iD, Sergio Bernardini, Annalisa Noce iD

Nutrients · 2025

DOI: 10.3390/nu17030413 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Kevin Cornali und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, PhD School in Biochemistry and Molecular Biology, University of Rome Tor Vergata, 00133 Rome, Italy. Hauptthemen laut MEDLINE: Palmitic Acids, Metabolic Syndrome, Dietary Supplements, Amides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic syndrome (MetS) patients have impaired hypothalamic regulatory functions involved in food intake and energy expenditure and suffer from a state of meta-inflammation. Pre-clinical studies demonstrated that ultramicronized palmitoylethanolamide (PEA) acts both on the adipose tissue and the central nervous system, while hydroxytyrosol (HTyr) counteracts several types of dysmetabolism.

Objectives

The aim of our randomized crossover double-blind placebo-controlled pilot study was to evaluate the potential effects of a food supplement (FS) containing a co-micronized formulation of PEA and rutin along with HTyr, combined with a tailored calorie-controlled Mediterranean diet, in patients with MetS.

Methods

Nineteen patients were enrolled and block-randomized to an eight-week MD together with the FS or placebo. After a two-week washout period, the treatments were reversed. Data on laboratory parameters and those detected by capillary sampling, anthropometry, body composition analysis, ultrasound examination, blood pressure monitoring, the 36-Item Short-Form Health Survey questionnaire, handgrip strength test, and physical performance tests were collected at each time point (protocol code R.S. 262.22, registered on 20 December 2022).

Results

At the end of the study, patients supplemented with the FS showed a significant reduction in body weight, body mass index, fat mass, and inflammation biomarkers (CRP and ESR), compared to placebo-supplemented patients. In contrast, the fat-free mass, phase angle, and body cell mass were increased in FS compared to placebo patients.

Conclusions

Although preliminary, the results of our clinical study suggest that co-micronized PEA–rutin and HTyr may be of help against adiposopathy in patients with MetS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Palmitic AcidsMetabolic SyndromeDietary SupplementsAmidesPhenylethyl AlcoholEthanolaminesHumansMaleFemaleMiddle AgedDouble-Blind MethodPilot ProjectsCross-Over StudiesAdultDiet, MediterraneanAgedTreatment Outcome

Stichwörter der Autor:innen

adiposopathybody composition assessmentco-micronized palmitoylethanolamidehydroxytyrosolmediterranean dietmeta-inflammationmetabolic syndromenatural bioactive compoundsrutin

Substanzen

Palmitic AcidspalmidrolAmidesPhenylethyl Alcohol3,4-dihydroxyphenylethanolEthanolamines

Autor:innen und Institutionen

  • Department of Experimental Medicine, PhD School in Biochemistry and Molecular Biology, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
  • School of Specialization in Nephrology, University of Rome Tor Vergata, 00133 Rome, Italy.
  • Unit of Laboratory Medicine, University Hospital Tor Vergata, 00133 Rome, Italy.
  • Innovative Statistical Research, 35100 Padua, Italy.
  • Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.

ORCID-Profile: Kevin Cornali, Manuela Di Lauro, Giulia Marrone, Giulia Montalto, Carlo Schievano, Massimo Pieri, Annalisa Noce

Zitieren

APA

Cornali, K., Di Lauro, M., Marrone, G., Masci, C., Montalto, G., Giovannelli, A., Schievano, C., Tesauro, M., Pieri, M., Bernardini, S., & Noce, A. (2025). The Effects of a Food Supplement, Based on Co-Micronized Palmitoylethanolamide (PEA)–Rutin and Hydroxytyrosol, in Metabolic Syndrome Patients: Preliminary Results. Nutrients. https://doi.org/10.3390/nu17030413

Vancouver

Cornali K, Di Lauro M, Marrone G, Masci C, Montalto G, Giovannelli A, et al. The Effects of a Food Supplement, Based on Co-Micronized Palmitoylethanolamide (PEA)–Rutin and Hydroxytyrosol, in Metabolic Syndrome Patients: Preliminary Results. Nutrients. 2025. doi:10.3390/nu17030413

BibTeX
@article{Cornali2025,
  author = {Cornali, Kevin and Di Lauro, Manuela and Marrone, Giulia and Masci, Claudia and Montalto, Giulia and Giovannelli, Alfredo and Schievano, Carlo and Tesauro, Manfredi and Pieri, Massimo and Bernardini, Sergio and Noce, Annalisa},
  title = {The Effects of a Food Supplement, Based on Co-Micronized Palmitoylethanolamide (PEA)–Rutin and Hydroxytyrosol, in Metabolic Syndrome Patients: Preliminary Results},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17030413}
}
Kostenlos starten →